Fairvalue-Calculator Fairvalue-Calculator
EN DE

Fortress Biotech, Inc (FBIO) Fair Value & Analysis

Healthcare · US · Market cap $99.3M

Price$3.16
Fair Value$4.51
Upside+42.7%
Quality85/100
Evidence: Medium Range $3.39 – $5.64

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Fortress Biotech, Inc (FBIO) currently trades at $3.16, while our model-based Fair Value estimate is $4.51 — implying the stock looks roughly 42.7% undervalued today. We read business quality at 85/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne; Amzeeq, a minocycline topical foam for the treatment of lesions of non-nodular moderate to severe acne vulgaris; Zilxi, a minocycline topical foam for the treatment of lesions of rosacea; Exelderm, an antifungal cream for topical use; Targadox, an oral doxycycline drug for the therapy of severe acne; Luxamend, a water-based emulsion for the treatment of superficial wounds, minor cuts or scrapes, dermal ulcers, donor sites, first and second-degree burns, and radiation dermatitis; and UNLOXCYT, a death-ligand 1 blocking antibody for the treatment of metastatic cutaneous sq…

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Fortress Biotech, Inc (FBIO) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $4.51 versus a price of $3.16 — about +43% (undervalued). Model-based estimate, not financial advice.
What is the fair value of FBIO?
Our 21-model fair value for Fortress Biotech, Inc is $4.51 (as of Jun 24, 2026), built from audited fundamentals. The current price is $3.16.
What is the quality score of FBIO?
Fortress Biotech, Inc has a Quality Score of 85/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.